Education
About Us
Working with TipRanks
Follow Us
Entheon Biomedical Corp. (TSE:ENBI)
:ENBI
RESEARCH TOOLSreports
ENBI Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.09 - C$0.45
Previous CloseN/A
Volume100.00
Average Volume (3M)13.31K
Market Cap
C$1.46M
Enterprise ValueC$1.12M
Total Cash (Recent Filing)C$525.16K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta2.39
Next Earnings
Oct 23, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding13,858,926
10 Day Avg. Volume9,254
30 Day Avg. Volume13,308
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)7.46
Price to Sales (P/S)0.00
P/FCF Ratio-3.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Entheon Biomedical News
ENBI FAQ
What was Entheon Biomedical Corp.’s price range in the past 12 months?
Entheon Biomedical Corp. lowest stock price was C$0.09 and its highest was C$0.45 in the past 12 months.
What is Entheon Biomedical Corp.’s market cap?
Entheon Biomedical Corp.’s market cap is C$1.46M.
When is Entheon Biomedical Corp.’s upcoming earnings report date?
Entheon Biomedical Corp.’s upcoming earnings report date is Oct 23, 2025 which is in 75 days.
How were Entheon Biomedical Corp.’s earnings last quarter?
Entheon Biomedical Corp. released its earnings results on Jul 18, 2025. The company reported -C$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.005.
Is Entheon Biomedical Corp. overvalued?
According to Wall Street analysts Entheon Biomedical Corp.’s price is currently Overvalued.
Does Entheon Biomedical Corp. pay dividends?
Entheon Biomedical Corp. does not currently pay dividends.
What is Entheon Biomedical Corp.’s EPS estimate?
Entheon Biomedical Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Entheon Biomedical Corp. have?
Entheon Biomedical Corp. has 13,858,926 shares outstanding.
What happened to Entheon Biomedical Corp.’s price movement after its last earnings report?
Entheon Biomedical Corp. reported an EPS of -C$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -16.667%.
Which hedge fund is a major shareholder of Entheon Biomedical Corp.?
Currently, no hedge funds are holding shares in TSE:ENBI
Company Description
Entheon Biomedical Corp.
Entheon Biomedical (ENBI) is a biotechnology company focused on the research and development of psychedelic-based therapeutic solutions to treat addiction and other mental health disorders. Operating within the biopharmaceutical sector, Entheon is dedicated to advancing the scientific understanding and clinical application of psychedelic compounds, particularly DMT (N,N-Dimethyltryptamine), to address unmet medical needs.
Technical Analysis
Ownership Overview
5.48% Insiders
―
Mutual Funds
― Other Institutional Investors
94.52% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---